SCHEMBL22019718

SCHEMBL22019718

Cc1c2c(nc3c1CCC3C)CCC2

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 10/20 0.38
HRH2 P25021 5/20 0.38
KDM4E B2RXH2 3/20 0.36
NLRP3 Q96P20 1/20 0.35
ACHE P22303 2/20 0.34
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
KMT2A Q03164 1/20 0.34
BPTF Q12830 1/20 0.34
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
CDC7 O00311 1/20 0.31
DBF4 Q9UBU7 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22020826 1.00 HRH3 (0.38) HRH3HRH2KDM4ENLRP3ACHE
SCHEMBL22021272 1.00 HRH3 (0.38) HRH3HRH2KDM4ENLRP3ACHE
SCHEMBL22282198 0.82 HRH3 (0.38) HRH3HRH2
SCHEMBL24979122 0.81 ACHE (0.55) HRH3HRH2KDM4EACHEMEN1
SCHEMBL30120762 0.81 ACHE (0.55) HRH3HRH2KDM4EACHEMEN1
SCHEMBL21962929 0.81 ACHE (0.55) HRH3HRH2KDM4EACHEMEN1
SCHEMBL21962895 0.81 ACHE (0.55) HRH3HRH2KDM4EACHEMEN1
SCHEMBL30162092 0.81 ACHE (0.55) HRH3HRH2KDM4EACHEMEN1
SCHEMBL24977969 0.78 NLRP3 (0.38) HRH3HRH2KDM4ENLRP3ACHE
SCHEMBL24978209 0.78 HRH3 (0.36) HRH3HRH2KDM4ENLRP3ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020154499-A1 SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-07-30 WO disclosed
WO-2020102096-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed